Category: Pharmacoengineering and Molecular Pharmaceutics
Nanomedicine Expert Russell Mumper Joins School Faculty
July 12, 2007Russell Mumper, PhD, an internationally recognized leader in the pharmaceutical applications of nanotechnology, has joined the UNC School of Pharmacy as the John A. McNeill Distinguished Professor. Mumper, an expert in vaccine and cancer drug delivery systems, will serve as the director of the School’s new Center for Nanotechnology in Drug Delivery. The CNDD is part of a larger nanomedicine initiative at UNC that bridges disciplines in medicine, chemistry, and pharmacy. The center’s central mission is to quickly and safely translate new nanotechnologies into human clinical trials to improve the quality of life. The CNDD will bring together scientists to … Read more
UNC Spin-off Licenses Technology to Drug Development Company
December 14, 2006Qualyst, a company created based on discoveries made at the UNC School of Pharmacy, announced that Covance Laboratories Inc., has licensed the use of Qualyst’s B-CLEAR® system to provide its pharmaceutical and biotechnology sponsors with pharmacokinetic services. B-CLEAR® is a sandwich-cultured hepatocyte system for the in vitro assessment and in vivo prediction of critical pharmacokinetic properties, including hepatobiliary disposition, hepatic uptake, hepatic accumulation, biliary clearance and drug transport. B-CLEAR® offers research organizations the ability to generate physiologically-relevant data and enable decision making in critical areas related to hepatic transport and adverse drug interactions, helping to avoid costly drug-development challenges and … Read more
Olson Named GSK Fellow
August 1, 2006Emily Olson, a graduate student in the Division of Molecular Pharmaceutics, has been awarded the 2006-2007 GlaxoSmithKline Fellowship. “The Graduate Student Organization and the graduate education committee have made an excellent choice by selecting Emily for the 2006-2007 GSK fellowship,” said Dhiren Thakker, associate dean of research and graduate education. “Their choice was based on Emily’s leadership and her many contributions to the graduate program at the School of Pharmacy in her role as the president of the GSO. Emily was an excellent spokesperson for students on the strategic planning committee, and contributed in a very meaningful way to the development of the strategic plan for the School. Clearly, … Read more
Xiao Appointed Fred Eshelman Distinguished Professor of Gene Therapy
June 12, 2006Xiao Xiao, PhD, has been appointed Fred Eshelman Distinguished Professor of Gene Therapy in the Division of Molecular Therapeutics in the UNC School of Pharmacy. Before coming to the School, Xiao was an associate professor at the University of Pittsburgh School of Medicine where he held several joint appointments. He was also an adjunct professor at Huazhong Science and Technology University Tongji Medical College in Wuhan, China, and a guest professor at Fudan University Shanghai Medical College in Shanghai, China. In 1982 Xiao received a BS in pharmaceutical chemistry from the Shanghai Medical University School of Pharmacy. He received a MS … Read more
Hadzija Wins Massey Award for Service
December 14, 2005Six UNC-Chapel Hill employees win prestigious Massey award for service By SUSAN PHILLIPS University Gazette Six employees have been selected by Chancellor James Moeser to be honored with 2005 C. Knox Massey Distinguished Awards, one of the most coveted distinctions bestowed by the University. Recipients are: Paul Spencer Davis of Chapel Hill, maintenance mechanic, Facilities Services; Boka Hadzija of Chapel Hill, professor, School of Pharmacy; Sue Hester of Graham, University administrative manager, UNC Honors Program and James M. Johnston Center for Undergraduate Excellence; Shirley Ort of Chapel Hill, associate provost and director of scholarships and student aid; Betty Russell of … Read more
SOP Faculty Honored for Patents that Help Economy, Improve Lives
June 15, 2005UNC inventors honored for patents with potential to help economy, improve lives CHAPEL HILL – During the past two decades, the University of North Carolina at Chapel Hill has become one of the top U.S. public universities in research support, with $577.6 million in sponsored research funding during the fiscal year ending in June 2004. That support – from federal government, other government and private sources – has funded research leading to patented discoveries. The U.S. Patent and Trademark Office issued 26 patents in 2004 that were assigned to UNC, university officials recently announced. “These patents, in turn, often are developed … Read more